With the increasing use of antibiotics, multidrug resistance in pathogenic bacteria has grown to become a medical crisis to public health. Multidrug efflux pumps play an important role in conferring drug resistance, as they are capable of expelling a variety of toxic substrates from the cell. Targeting assembly of efflux pumps is a promising strategy to overcoming antibiotic resistance [1] . In Gramnegative bacteria, these pumps form tripartite assemblies that span both the inner and outer membranes making them difficult for traditional structural studies [2].
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AcrAB-TolC is one of the tripartite pumps that are constitutively expressed in Escherichia coli (E. coli) [3] . As the main multidrug efflux machinery, AcrAB-TolC is comprised of the outer membrane protein TolC, the periplasmic adaptor protein AcrA, and the inner membrane transporter AcrB from the Resistance-Nodulation-cell Division (RND) superfamily [2] . The AcrAB-TolC efflux pump transports diverse compounds, conferring resistance to a broad spectrum of antibiotics [4] . Structural studies of this pump have been limited to individual components by X-ray crystallography [5] [6] [7] [8] or fully assembled pumps by cryo-electron microscopy (cryo-EM) single particle analysis [9, 10] .
We have now visualized the first in situ structure of AcrAB-TolC efflux pump at 15Å resolution in bacteria cell using electron cryo-tomography and subtomogram averaging. There is long time ambiguity about assembly process of tripartite pump in bacteria, our study for the first time, observed partially assembled complexes and their contacts with the peptidoglycan layer. In addition, the fully assembled efflux pump was visualized in an "open state" in the presence of AcrB inhibitor and a "closed state" in the presence of antibiotic, suggesting that the efflux of antibiotic is a transient cellular process in contrast to complexes in vitro. Taken together, these results reveal the assembly mechanism of tripartite efflux pumps in living bacteria and provide the structural basis for future therapeutic investigations of drug efflux pumps. 
